139 related articles for article (PubMed ID: 12505098)
1. Fc receptor blockade in patients with refractory chronic immune thrombocytopenic purpura with anti-D IgG.
Ambriz-Fernández R; Martínez-Murillo C; Quintana-González S; Collazo-Jaloma J; Bautista-Juárez J
Arch Med Res; 2002; 33(6):536-40. PubMed ID: 12505098
[TBL] [Abstract][Full Text] [Related]
2. [Use of anti-D (Rh) IgG or intramuscular polyvalent human immunoglobulin in the treatment of chronic autoimmune thrombocytopenic purpura].
Vizcaíno G; Diez-Ewald M; Arteaga-Vizcaíno M; Torres E
Invest Clin; 1992; 33(4):165-74. PubMed ID: 1338940
[TBL] [Abstract][Full Text] [Related]
3. Intravenous anti-D treatment of immune thrombocytopenic purpura: analysis of efficacy, toxicity, and mechanism of effect.
Bussel JB; Graziano JN; Kimberly RP; Pahwa S; Aledort LM
Blood; 1991 May; 77(9):1884-93. PubMed ID: 1850307
[TBL] [Abstract][Full Text] [Related]
4. Treatment of childhood idiopathic thrombocytopenic purpura with Rhesus antibodies (anti-D).
Becker T; Küenzlen E; Salama A; Mertens R; Kiefel V; Weiss H; Lampert F; Gaedicke G; Mueller-Eckhardt C
Eur J Pediatr; 1986 Aug; 145(3):166-9. PubMed ID: 3021462
[TBL] [Abstract][Full Text] [Related]
5. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
[TBL] [Abstract][Full Text] [Related]
6. Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to avoid splenectomy?
Cooper N; Woloski BM; Fodero EM; Novoa M; Leber M; Beer JH; Bussel JB
Blood; 2002 Mar; 99(6):1922-7. PubMed ID: 11877261
[TBL] [Abstract][Full Text] [Related]
7. Treatment of autoimmune thrombocytopenic purpura with rhesus antibodies (anti-Rh0(D).
Salama A; Kiefel V; Amberg R; Mueller-Eckhardt C
Blut; 1984 Jul; 49(1):29-35. PubMed ID: 6430368
[TBL] [Abstract][Full Text] [Related]
8. Long-term response in a patient with ITP following low dose anti-D immunoglobulin therapy.
Smith NA; Chakraverty RK; Obeid D; Boughton BJ
Autoimmunity; 1989; 4(1-2):115-7. PubMed ID: 2562380
[TBL] [Abstract][Full Text] [Related]
9. Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin.
Fehr J; Hofmann V; Kappeler U
N Engl J Med; 1982 May; 306(21):1254-8. PubMed ID: 6803159
[TBL] [Abstract][Full Text] [Related]
10. The infusion of anti-RhO-(D) opsonized erythrocytes may be useful in the treatment of patients, splenectomized or not, with chronic, refractory autoimmune thrombocytopenic purpura--a prospective study.
Ruiz-Argüelles GJ; Apreza-Molina MG; Pérez-Romano B; Ruiz-Argüelles A
Am J Hematol; 1993 May; 43(1):72-3. PubMed ID: 8317469
[TBL] [Abstract][Full Text] [Related]
11. A dose of 75 microg/kg/d of i.v. anti-D increases the platelet count more rapidly and for a longer period of time than 50 microg/kg/d in adults with immune thrombocytopenic purpura.
Newman GC; Novoa MV; Fodero EM; Lesser ML; Woloski BM; Bussel JB
Br J Haematol; 2001 Mar; 112(4):1076-8. PubMed ID: 11298610
[TBL] [Abstract][Full Text] [Related]
12. Intravenous anti-D treatment of immune thrombocytopenic purpura: experience in 272 patients.
Scaradavou A; Woo B; Woloski BM; Cunningham-Rundles S; Ettinger LJ; Aledort LM; Bussel JB
Blood; 1997 Apr; 89(8):2689-700. PubMed ID: 9108386
[TBL] [Abstract][Full Text] [Related]
13. A multicenter study of the treatment of childhood chronic idiopathic thrombocytopenic purpura with anti-D.
Andrew M; Blanchette VS; Adams M; Ali K; Barnard D; Chan KW; DeVeber LB; Esseltine D; Israels S; Korbrinsky N
J Pediatr; 1992 Apr; 120(4 Pt 1):522-7. PubMed ID: 1313096
[TBL] [Abstract][Full Text] [Related]
14. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura.
Blanchette V; Imbach P; Andrew M; Adams M; McMillan J; Wang E; Milner R; Ali K; Barnard D; Bernstein M
Lancet; 1994 Sep; 344(8924):703-7. PubMed ID: 7915773
[TBL] [Abstract][Full Text] [Related]
15. Intravenous gamma globulin treatment for chronic idiopathic thrombocytopenic purpura in children.
Warrier I; Lusher JM
Am J Med; 1984 Mar; 76(3A):193-8. PubMed ID: 6424451
[TBL] [Abstract][Full Text] [Related]
16. A single-institution, 20-year prospective experience with an affordable Fc-receptor blockade method to treat patients with chronic, refractory autoimmune thrombocytopenic purpura.
Estrada-Gómez R; Vargas-Castro O; Oropeza-Borges M; González-Carrillo ML; Pérez-Romano B; Ruiz-Argüelles GJ
Rev Invest Clin; 2007; 59(6):424-7. PubMed ID: 18402333
[TBL] [Abstract][Full Text] [Related]
17. Modulation of Fc receptor clearance and antiplatelet antibodies as a consequence of intravenous immune globulin infusion in patients with immune thrombocytopenic purpura.
Bussel JB
J Allergy Clin Immunol; 1989 Oct; 84(4 Pt 2):566-77; discussion 577-8. PubMed ID: 2677093
[TBL] [Abstract][Full Text] [Related]
18. Effect of intravenous immunoglobulin in immune thrombocytopenia.
Salama A; Mueller-Eckhardt C; Kiefel V
Lancet; 1983 Jul; 2(8343):193-5. PubMed ID: 6135031
[TBL] [Abstract][Full Text] [Related]
19. Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma-receptor antibody.
Clarkson SB; Bussel JB; Kimberly RP; Valinsky JE; Nachman RL; Unkeless JC
N Engl J Med; 1986 May; 314(19):1236-9. PubMed ID: 2939345
[No Abstract] [Full Text] [Related]
20. Idiopathic thrombocytopenic purpura.
Burns TR; Saleem A
Am J Med; 1983 Dec; 75(6):1001-7. PubMed ID: 6685977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
